Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Behavioral Ecology : Official Journal of the International Society for Behavioral Ecology
|
November 25, 2014
Negotiation of territorial boundaries in a songbird
Sandra L Vehrencamp, Jesse M Ellis, Brett F Cropp, et al.
Physical Review Letters
|
September 29, 2018
Electron Ghost Imaging
S Li, F Cropp, K Kabra, et al.
The Journal of the Acoustical Society of America
|
April 8, 2010
Spatial location influences vocal interactions in bullfrog choruses
Mary E Bates, Brett F Cropp, Marina Gonchar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 28, 2013
Interactive effects of dehydroepiandrosterone and testosterone on cortical thickness during early brain development
Tuong-Vi Nguyen, James T McCracken, Simon Ducharme, et al.
Investigational New Drugs
|
August 10, 2011
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors
J Paul Monk, Miguel Villalona-Calero, Joe Larkin, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
Elaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P C Adamson, S M Blaney, B C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study
Shanu Modi, Alison T Stopeck, Michael S Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors
Bart C Kuenen, Lee Rosen, Egbert F Smit, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Behavioral Ecology : Official Journal of the International Society for Behavioral Ecology
|
November 25, 2014
Negotiation of territorial boundaries in a songbird
Sandra L Vehrencamp, Jesse M Ellis, Brett F Cropp, et al.
Physical Review Letters
|
September 29, 2018
Electron Ghost Imaging
S Li, F Cropp, K Kabra, et al.
The Journal of the Acoustical Society of America
|
April 8, 2010
Spatial location influences vocal interactions in bullfrog choruses
Mary E Bates, Brett F Cropp, Marina Gonchar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 28, 2013
Interactive effects of dehydroepiandrosterone and testosterone on cortical thickness during early brain development
Tuong-Vi Nguyen, James T McCracken, Simon Ducharme, et al.
Investigational New Drugs
|
August 10, 2011
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors
J Paul Monk, Miguel Villalona-Calero, Joe Larkin, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
Elaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P C Adamson, S M Blaney, B C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study
Shanu Modi, Alison T Stopeck, Michael S Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors
Bart C Kuenen, Lee Rosen, Egbert F Smit, et al.
Page
of 2